128 related articles for article (PubMed ID: 18388221)
21. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors.
Kremer S; Grand S; Remy C; Esteve F; Lefournier V; Pasquier B; Hoffmann D; Benabid AL; Le Bas JF
J Neuroradiol; 2002 Jun; 29(2):105-13. PubMed ID: 12297732
[TBL] [Abstract][Full Text] [Related]
22. Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade.
Jain R; Griffith B; Alotaibi F; Zagzag D; Fine H; Golfinos J; Schultz L
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2030-5. PubMed ID: 26206809
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas.
Di Ieva A; Göd S; Grabner G; Grizzi F; Sherif C; Matula C; Tschabitscher M; Trattnig S
Neuroradiology; 2013 Jan; 55(1):35-40. PubMed ID: 22903580
[TBL] [Abstract][Full Text] [Related]
24. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
[TBL] [Abstract][Full Text] [Related]
25. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
26. Characterization of glioma microcirculation and tissue features using intravoxel incoherent motion magnetic resonance imaging in a rat brain model.
Iima M; Reynaud O; Tsurugizawa T; Ciobanu L; Li JR; Geffroy F; Djemai B; Umehana M; Le Bihan D
Invest Radiol; 2014 Jul; 49(7):485-90. PubMed ID: 24619211
[TBL] [Abstract][Full Text] [Related]
27. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
28. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging.
Zhu XP; Li KL; Kamaly-Asl ID; Checkley DR; Tessier JJ; Waterton JC; Jackson A
J Magn Reson Imaging; 2000 Jun; 11(6):575-85. PubMed ID: 10862055
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
30. Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors.
Ho CY; Cardinal JS; Kamer AP; Kralik SF
Neuroradiology; 2015 Mar; 57(3):299-306. PubMed ID: 25504266
[TBL] [Abstract][Full Text] [Related]
31. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas.
Jackson A; Kassner A; Zhu XP; Li KL
J Magn Reson Imaging; 2001 Nov; 14(5):510-6. PubMed ID: 11747002
[TBL] [Abstract][Full Text] [Related]
32. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
[TBL] [Abstract][Full Text] [Related]
33. High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.
Aprile I; Giovannelli G; Fiaschini P; Muti M; Kouleridou A; Caputo N
Radiol Med; 2015 Oct; 120(10):967-74. PubMed ID: 25762408
[TBL] [Abstract][Full Text] [Related]
34. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
35. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A
Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536
[TBL] [Abstract][Full Text] [Related]
36. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
37. Hierarchical non-negative matrix factorization to characterize brain tumor heterogeneity using multi-parametric MRI.
Sauwen N; Sima DM; Van Cauter S; Veraart J; Leemans A; Maes F; Himmelreich U; Van Huffel S
NMR Biomed; 2015 Dec; 28(12):1599-624. PubMed ID: 26458729
[TBL] [Abstract][Full Text] [Related]
38. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Law M; Young RJ; Babb JS; Peccerelli N; Chheang S; Gruber ML; Miller DC; Golfinos JG; Zagzag D; Johnson G
Radiology; 2008 May; 247(2):490-8. PubMed ID: 18349315
[TBL] [Abstract][Full Text] [Related]
39. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.
Aronen HJ; Pardo FS; Kennedy DN; Belliveau JW; Packard SD; Hsu DW; Hochberg FH; Fischman AJ; Rosen BR
Clin Cancer Res; 2000 Jun; 6(6):2189-200. PubMed ID: 10873068
[TBL] [Abstract][Full Text] [Related]
40. Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis.
Jallo GI; Friedlander DR; Kelly PJ; Wisoff JH; Grumet M; Zagzag D
Neurosurgery; 1997 Nov; 41(5):1052-9. PubMed ID: 9361058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
